Cambridge Investment Research Advisors
VIOV icon

Cambridge Investment Research Advisors’s Vanguard S&P Small-Cap 600 Value ETF VIOV Stock Holding History

Cambridge Investment Research Advisors’s Portfolio VIOV Stock Details VIOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.23M Buy
61,645
+466
+0.8% +$51.6K 0.02% 830
2026
Q1 		$6.22M Sell
61,179
-19,388
-24% -$2.01M 0.02% 844
2025
Q4 		$7.88M Buy
80,567
+301
+0.4% +$29K 0.02% 689
2025
Q3 		$7.64M Buy
80,266
+8,814
+12% +$807K 0.02% 695
2025
Q2 		$6.11M Buy
71,452
+1,352
+2% +$110K 0.02% 741
2025
Q1 		$5.88M Buy
70,100
+7,440
+12% +$675K 0.02% 719
2024
Q4 		$5.85M Buy
62,660
+47,269
+307% +$4.51M 0.02% 716
2024
Q3 		$1.42M Buy
15,391
+485
+3% +$43.3K ﹤0.01% 1595
2024
Q2 		$1.25M Buy
14,906
+142
+1% +$12K ﹤0.01% 1616
2024
Q1 		$1.3M Sell
14,764
-19,396
-57% -$1.65M 0.01% 1553
2023
Q4 		$3.02M Buy
34,160
+17,184
+101% +$1.35M 0.01% 967
2023
Q3 		$1.31M Buy
16,976
+2,802
+20% +$230K 0.01% 1404
2023
Q2 		$1.16M Sell
14,174
-8,232
-37% -$650K 0.01% 1504
2023
Q1 		$1.81M Buy
22,406
+5,756
+35% +$485K 0.01% 1186
2022
Q4 		$1.31M Sell
16,650
-4,318
-21% -$344K 0.01% 1338
2022
Q3 		$1.5M Buy
20,968
+5,516
+36% +$442K 0.01% 1214
2022
Q2 		$1.19M Buy
15,452
+1,050
+7% +$87.2K 0.01% 1347
2022
Q1 		$1.28M Sell
14,402
-3,830
-21% -$337K 0.01% 1406
2021
Q4 		$1.65M Sell
18,232
-10,346
-36% -$938K 0.01% 1256
2021
Q3 		$2.49M Sell
28,578
-36,078
-56% -$3.15M 0.01% 974
2021
Q2 		$5.89M Buy
64,656
+6,196
+11% +$560K 0.03% 545
2021
Q1 		$5.09M Buy
58,460
+51,300
+716% +$4.19M 0.03% 556
2020
Q4 		$503K Sell
7,160
-3,214
-31% -$203K ﹤0.01% 1766
2020
Q3 		$551K Sell
10,374
-3,032
-23% -$165K ﹤0.01% 1545
2020
Q2 		$700K Buy
13,406
+3,912
+41% +$190K 0.01% 1344
2020
Q1 		$411K Buy
9,494
+1,016
+12% +$60.8K ﹤0.01% 1494
2019
Q4 		$589K Sell
8,478
-204
-2% -$13.6K ﹤0.01% 1480
2019
Q3 		$563K Sell
8,682
-1,548
-15% -$98.2K ﹤0.01% 1422
2019
Q2 		$656K Sell
10,230
-104
-1% -$6.67K 0.01% 1270
2019
Q1 		$658K Buy
10,334
+780
+8% +$49.7K 0.01% 1300
2018
Q4 		$543K Sell
9,554
-2,190
-19% -$140K 0.01% 1271
2018
Q3 		$845K Sell
11,744
-9,408
-44% -$686K 0.01% 1127
2018
Q2 		$1.49M Buy
21,152
+11,344
+116% +$783K 0.02% 766
2018
Q1 		$639K Buy
9,808
+2,496
+34% +$166K 0.01% 1204
2017
Q4 		$484K Buy
7,312
+182
+3% +$11.8K 0.01% 1343
2017
Q3 		$456K Buy
+7,130
New +$429K 0.01% 1296
2016
Q3 		– Sell
-4,844
Closed -$243K – 1791
2016
Q2 		$243K Buy
4,844
+104
+2% +$5.14K 0.01% 1291
2016
Q1 		$231K Buy
4,740
+246
+5% +$11K 0.01% 1324
2015
Q4 		$211K Buy
+4,494
New +$214K 0.01% 1337
2015
Q3 		– Sell
-4,774
Closed -$244K – 1589
2015
Q2 		$244K Sell
4,774
-248
-5% -$12.7K 0.01% 1165
2015
Q1 		$258K Sell
5,022
-78
-2% -$3.9K 0.01% 1121
2014
Q4 		$259K Sell
5,100
-1,474
-22% -$72K 0.01% 1081
2014
Q3 		$306K Buy
6,574
+1,670
+34% +$81.2K 0.01% 1086
2014
Q2 		$244K Buy
4,904
+254
+5% +$12.2K 0.01% 1102
2014
Q1 		$227K Buy
4,650
+208
+5% +$9.86K 0.01% 1102
2013
Q4 		$212K Buy
+4,442
New +$204K 0.01% 1054

Other funds holding VIOV

AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
RA
Riversedge Advisors Wilmington, Delaware $759M AUM 24.25% 1-Year Est. Return
LFA
Legend Financial Advisors Pittsburgh, Pennsylvania $176M AUM 57.06% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Cambridge Investment Research Advisors's VIOV Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Vanguard S&P Small-Cap 600 Value ETF (VIOV) stake by 0.76% in Q2 2026, buying an estimated $51.6K and bringing the position to 61,645 shares worth $7.23M. The position accounts for 0.02% of the portfolio, ranked #830.

Cambridge Investment Research Advisors first reported a position in VIOV in Q4 2013 and has held it in 46 quarters since. The position peaked at $7.88M in Q4 2025. 84 funds tracked by Wall St. Rank hold VIOV as of Q2 2026.

  • Cambridge Investment Research Advisors held 61,645 shares of Vanguard S&P Small-Cap 600 Value ETF worth $7.23M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 466 Vanguard S&P Small-Cap 600 Value ETF shares in Q2 2026, an estimated $51.6K.
  • Vanguard S&P Small-Cap 600 Value ETF made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #830 holding.
  • Cambridge Investment Research Advisors first reported a position in Vanguard S&P Small-Cap 600 Value ETF in Q4 2013 and has held it in 46 quarters since.
  • Cambridge Investment Research Advisors's Vanguard S&P Small-Cap 600 Value ETF position peaked at $7.88M in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Vanguard S&P Small-Cap 600 Value ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.